This application claims priority from provisional No. 63/004,980, filed Apr. 3, 2020, the entire contents of which are herewith incorporated by reference.
Biological catalysts such as enzymes in electrochemical devices can be highly specific and potentially very effective catalyzers of nearly any analyte.
Stability is often a bottleneck to sustained performance in applications of bio-powered technology. Once a biological unit, such as an enzyme, is put into solution, it will start to naturally decompose.
A common way to keep such units fresh is to refrigerate, freeze or lyophilize batches and dissolve them immediately before use. Indeed, most biological assays and test kits have temperature sensitive biological components.
In a freestanding device, however, it is usually not possible to maintain a low-temperature compartment for storing unused active compounds.
A most common portable enzymatic devices on the market include glucose monitors powered by glucose oxidase (GOx). While some progress has been made to stabilize GOx for a few weeks, the measurement device needs to be supplied with fresh preparations of enzyme intermittently. This is commonly done using interchangeable cassettes or chips containing fresh enzyme. However, when using biological components with much shorter hydrated lifetime frequent cassette exchanges makes the device too burdensome to use.
In a state-of-the-art wearable alcohol biosensor (Lansdorp et al, Sensors, 2019), enzyme was fully hydrated within a short period of time, and the sensor was observed to stop functioning after 24 hours, due to the loss of enzyme activity.
Prior art makes mention of open-form cylindrical devices for controlled drug release (U.S. Pat. No. 5,851,547A), however this prior art fails to consider the application of catalysts to a biosensor, where extended release of catalysts can improve biosensor lifetime.
Prior art also mentions the use of immobilization protocols and molecular modulation to improve the longevity of a sensing device using enzymes, most often including the use of aldehydes and other crosslinkers (US20170009270A1). However, many biocatalysts are either inhibited by such modifications or completely deactivated. Therefore, what is desired is a means of extending the operational life of enzyme-based devices without the use of harmful chemicals.
Therefore, the inventors recognize the need for an integrated solution to replenish active biological components to a bioelectronic device. Having an integrated system is especially useful in wearable monitoring devices.
The present invention describes structure and methods for the slow and sustained release of catalysts from an isolated compartment.
This invention describes a small integratable compartment with stabilized biological components that are slowly added to a solution over time.
In another embodiment, the shape of the cylindrical container biocatalyst well has a radius that varies with length such as a cone. In another, the biocatalyst well is not cylindrical, but rectangular, or other geometric shapes. The container itself is liquid impermeable, but has an opening with a specified geometry. The container can be formed of plastic, rubber, glass, or metal, or other materials known to those of ordinary skill in the art. The opening is used, as described herein, to expose to the biocatalyst to liquid at a controlled rate.
In another embodiment, shown in
The compartments may be sealed using heat-sealable films, adhesive films, or other water-impermeable materials or peelable seals familiar to those skilled in the art.
In this pre-activated configuration, where the dry is separate from the wet, the cartridge is stable for 6 months.
To activate the cartridge, the cylindrical container 4 can be immersed into the liquid compartment 10 containing a buffer, by folding together the two compartments 8 and 10 by means of a hinge 12. The cartridge 6 can be attached to a wristband housing 14 that connects to a strap 16. Once the 2 compartments have been folded together, the liquid starts the diffusion process and activates dissolved biocatalyst, allowing the cartridge to carry out a chemical reaction. A signal measuring device 120 on the wearable platform measures the signal induced by the chemical reaction using the cartridge and its reaction with analytes diffusing through the skin 18. The signal measuring device 120 can use amperometric measurements through cartridge electrodes. The signal measuring device 120 can communicate the signal wirelessly, for example, to a receiver. Thus, the cartridge can be activated by folding together the 2 parts 8 and 10 which thus exposes the cartridge to the liquid, allowing at that point transdermal sensing of alcohol non-invasively after strapping the embodiment on skin 18.
The release rate of fresh enzymes from the device is tuned by the opening size, as well as by other techniques described herein, to match the deactivation rate of the enzymes in the liquid compartment. This embodiment enables alcohol oxidase to be slowly added to the liquid compartment, extending the lifetime of the cartridge over those in the prior art, for example from 24 hours of continuous sensing up to 72 hours or more of continuous sensing, a substantial improvement over prior art.
In another embodiment, container 4 can be loaded with more than one type of resin, for example with biocatalyst and stabilizer, as seen in
Alternatively, the rate of dispersion can be adjusted using a cylinder that varies by length, such as a cone. A widening diameter will increase dispersion rate due to an increase in exposed surface area of the resin. Similarly, a narrowing diameter will decrease the dispersion rate. Adjusting dispersion rate has the advantage of enabling a device to quickly fill with a biocatalyst to reach a saturated condition, and maintain saturation for an extended period of time.
In one embodiment, shown in
Alternatively, the catalyst can be embedded using the water-soluble material that has one or more compounds of limited solubility. The compounds of limited solubility can be an organic or inorganic wax, a cellulose material, or starch material, in embodiments.
For the geometry described above, the transparent cylinder 4 containing resin 24 was placed in a transparent eppendorf tube with 1 mL PBS containing 0.25% agarose gel and sealed. To track the interface, a time-lapse photographic series was taken, with intervals of 10 minutes, starting at the time the loaded container 4 was submerged into the liquid (see
The results for the embodiment shown in
Dispersion rate of any mixture of biocatalysts and stabilizers can be measured by means of a visual tracking of the receding deposit-liquid interface. Thus, the dispersion rate for a specific container geometry can be estimated as follows:
Where σresin is the resin dispersion rate in mm/day and Δd/Δt is the receding interface in millimeters per unit time. The rate of increase is initially high, and then reaches a steady state rate of dispersion of 1.6 mm/day. In contrast, the same amount of lyophilized and stabilized enzyme mixed directly into the liquid disperses within seconds. This demonstrates a reduction to practice of a diffusion controlled release of alcohol oxidase enzyme into a liquid solution.
The general assembly process flowchart of an embodiment integrated in a biosensor is shown in the flowchart of
Once loaded, the exposed end of the device can be covered by a plastic cap, metallized film, water impermeable material, or other materials familiar to those skilled in the art. Container 4 may also be formed by injection molding of plastic, machining of metals by drill, or other forms familiar to those skilled in the art.
Although only a few embodiments have been disclosed in detail above, other embodiments are possible and the inventors intend these to be encompassed within this specification.
The previous description of the disclosed exemplary embodiments is provided to enable any person skilled in the art to make or use the present invention. Various modifications to these exemplary embodiments will be readily apparent to those skilled in the art, and the generic principles defined herein may be applied to other embodiments without departing from the spirit or scope of the invention. Thus, the present invention is not intended to be limited to the embodiments shown herein but is to be accorded the widest scope consistent with the principles and novel features disclosed herein.
This invention was made with government support under AA 026125, awarded by National Institute of Health (NIH). The government has certain rights in the invention.
Number | Date | Country | |
---|---|---|---|
63004980 | Apr 2020 | US |